Law360, New York (November 13, 2009, 4:43 PM ET) -- The U.S. Food and Drug Administration has warned health care professionals about the risk of chondrolysis in patients who were given continuous intra-articular infusions of local anesthetics with elastomeric infusion devices to control post-surgical pain.
Because of the adverse events, the FDA said Friday that it was requiring drug manufacturers to update their product labels to warn health care professionals about the potentially serious side effect. The FDA also will require the manufacturers of pumps that may be used to infuse local anesthetics, including elastomeric infusion...
FDA Warns Public About Post-Surgery Infusions
To view the full article, take a free trial now.
